Navigation Links
First comprehensive guidelines for managing medullary thyroid carcinoma published in Thyroid journal
Date:5/27/2009

New Rochelle, NY, May 27, 2009New guidelines designed to standardize and optimize the diagnosis, treatment, and monitoring of patients with Medullary Thyroid Carcinoma (MTC), an uncommon and challenging form of thyroid cancer, have been developed by the American Thyroid Association and published online ahead of print in Thyroid, a peer-reviewed journal published by Mary Ann Liebert, Inc. (www.liebertpub.com). The guidelines are available free online at www.liebertpub.com/thy

"Following careful peer review, Thyroid has published the first comprehensive set of clinical guidelines for the treatment of all medullary thyroid carcinoma (MTC) disorders," says Charles H. Emerson, MD, Editor-in-Chief of the Journal and Professor Emeritus at University of Massachusetts Medical School, in Worcester. "This form of thyroid cancer is especially important because of its high mortality, strong inheritance patterns, and associations with other serious glandular disorders. These evidence-based guidelines will become a benchmark for patient management and clinical research, as they illuminate the diagnostic and therapeutic strategies required when caring for gravely ill patients and those in the anxiety-ridden early stages of the disease, and when offering testing and counseling to family members."

MTC is a complex disease that accounts for about 4% of all thyroid cancer cases in the United States. Nearly 25% of cases worldwide are familial and present as an autosomal inherited disorder. In individuals with the inherited form of MTC, a preneoplastic lesion called C-cell hyperplasia will first develop and then progress to an invasive, life-threatening malignancy.

The American Thyroid Association (www.thyroid.org) has compiled 122 evidence-based recommendations that cover a range of clinical topics, including diagnosis and therapy for early disease, genetic testing, surgical management, post-surgical treatment and monitoring, management of persistent or recurrent MTC and metastatic disease, and long-term follow-up. The guidelines also propose directions for future research on MTC.

"Medullary thyroid cancer is a rare and fascinating disease that few health care professionals ever master," says Richard T. Kloos, MD, Chair of the ATA Guidelines Task Force, Secretary and Chief Operating Officer of the American Thyroid Association, and Co-Director of the Ohio State University Thyroid Cancer Unit. "The ATA guidelines promote optimal medical care that is grounded in an evidence-based review of the literature by an international and multidisciplinary panel. It is our hope that they will serve all the professionals that care for these patients, including those in the fields of endocrinology, genetics, pediatrics, radiology, nuclear medicine, surgery, and oncology."


'/>"/>

Contact: Vicki Cohn
vcohn@liebertpub.com
914-740-2156
Mary Ann Liebert, Inc./Genetic Engineering News
Source:Eurekalert

Related biology news :

1. First nanorust field test slated in Mexico
2. Aware, Inc. Reports First Quarter 2009 Financial Results
3. Uniloc Unveils Industry-First Authentication Technology for Comprehensive Protection of Critical Infrastructure
4. Validus and HierStar Form Strategic Alliance to Offer the First Complete Range of Authentication Products
5. Activated stem cells in damaged lungs could be first step toward cancer
6. ExcellGene SA first company to offer contract manufacturing in 250 Liter OrbShake bioreactor
7. MCG researcher among first to receive NIH stimulus funding
8. University of Florida study provides insight into evolution of first flowers
9. Study finds genetic links to age of first menstrual period and menopause
10. UCSD researchers make first direct observations of biological particles in high-altitude ice clouds
11. Genes that influence start of menstruation identified for first time
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2017)... Summary This report provides all the ... interests and activities since 2010. ... Read the full report: http://www.reportlinker.com/p03605615-summary/view-report.html ... report provides an in-depth insight into the partnering activity of ... On demand company reports are prepared upon purchase to ensure ...
(Date:3/2/2017)... LONDON , March 2, 2017 Who ... infringement lawsuits? Download the full report: https://www.reportbuyer.com/product/4313699/ ... ON THE FINGERPRINT SENSOR FIELD? Fingerprint sensors using ... smartphones. The fingerprint sensor vendor Idex forecasts an increase ... in mobile devices and of the fingerprint sensor market ...
(Date:3/1/2017)... 1, 2017  Aware, Inc. (NASDAQ: AWRE), a leading ... Richard P. Moberg has resigned, effective March 3, ... Financial Officer and Treasurer of Aware citing a desire ... a member of the Board of Directors of Aware. ... Executive Officer and co-President, General Counsel has been named ...
Breaking Biology News(10 mins):
(Date:3/23/2017)... ... March 23, 2017 , ... ... selected by the Connecticut Technology Council (CTC) as a 2017 Women of Innovation® ... annual Women of Innovation Awards Dinner. , The dinner recognizes women accomplished in ...
(Date:3/23/2017)... YORK , March 23, 2017 ... look at four equities in the Biotech industry: Sangamo ... Synthetic Biologics Inc. (NYSE MKT: SYN), and Regulus Therapeutics ... 21 st , 2017, Credit Suisse upgraded its rating on ... by downloading their free report at: ...
(Date:3/22/2017)... Calif. , March 22, 2017  UBM ... proud to announce their extended partnership and the ... be headlined by the 21 st Annual ... Boston, taking place May 3-4, 2017. ... Medical Technology Association (ADVAMED) President and CEO, ...
(Date:3/22/2017)... 2017 MarketNewsUpdates.com News Commentary  ... The traditional ways ... pressured as of late due to the rise of the ... a dramatic impact on patient,s quality of life as Biotech ... identifying new forms of opioid formulations that prevent abuse. Biotech ...
Breaking Biology Technology: